Generic Review At US FDA: Record Month Completes Approval Volume Recovery
With 96 full ANDA approvals and 30 tentative approvals, July was the most productive month since GDUFA launched.
You may also be interested in...
Thanks in large part to new elemental impurities requirements, ANDA approvals are behind the pace needed to beat 2017’s record.
Generic industry, FDA discuss potential ways to increase transparency so agency can better estimate when – and even whether – an ANDA receiving a complete response will be returned.
US FDA's generic approval total in January was dramatically lower than recent monthly tallies, raising questions about impact of requirements that took effect at beginning of the year.